መነሻEBS • NYSE
add
Emergent Biosolutions Inc
የቀዳሚ መዝጊያ
$9.88
የቀን ክልል
$9.25 - $9.78
የዓመት ክልል
$1.42 - $15.10
የገበያው አጠቃላይ ዋጋ
509.87 ሚ USD
አማካይ መጠን
1.04 ሚ
የዋጋ/ገቢ ምጥጥን
-
የትርፍ ክፍያ
-
ዋና ልውውጥ
NYSE
ፋይናንስ
የገቢ መግለጫ
ገቢ
የተጣራ ገቢ
(USD) | ሴፕቴ 2024info | ከዓመት ዓመት ለውጥ |
---|---|---|
ገቢ | 293.80 ሚ | 8.61% |
የሥራ ወጪ | 92.20 ሚ | -3.96% |
የተጣራ ገቢ | 114.80 ሚ | 143.58% |
የተጣራ የትርፍ ክልል | 39.07 | 140.12% |
ገቢ በሼር | 1.37 | — |
EBITDA | 97.70 ሚ | 319.31% |
ውጤታማ የግብር ተመን | 19.38% | — |
ቀሪ ሒሳብ ሉሆች
አጠቃላይ ንብረቶች
አጠቃላይ ተጠያቂነቶች
(USD) | ሴፕቴ 2024info | ከዓመት ዓመት ለውጥ |
---|---|---|
ጥሬ ገንዘብና የአጭር ጊዜ መዋዕለ ንዋይ | 149.90 ሚ | 70.73% |
አጠቃላይ ንብረቶች | 1.48 ቢ | -21.94% |
አጠቃላይ ተጠያቂነቶች | 969.40 ሚ | -18.94% |
አጠቃላይ እሴት | 508.40 ሚ | — |
የሼሮቹ ብዛት | 54.18 ሚ | — |
የገበያ ዋጋ እና የተገለጸ ዋጋ | 1.05 | — |
የእሴቶች ተመላሽ | 12.03% | — |
የካፒታል ተመላሽ | 14.71% | — |
የገንዘብ ፍሰት
የተጣራ ዝርዝር ገንዘብ በጥሬ ገንዘብ
(USD) | ሴፕቴ 2024info | ከዓመት ዓመት ለውጥ |
---|---|---|
የተጣራ ገቢ | 114.80 ሚ | 143.58% |
ከክወናዎች የተገኘ ጥሬ ገንዘብ | 153.70 ሚ | 156.17% |
ገንዘብ ከኢንቨስትመንት | 112.00 ሚ | 692.59% |
ገንዘብ ከፋይናንስ | -180.30 ሚ | -319.30% |
የተጣራ ዝርዝር ገንዘብ በጥሬ ገንዘብ | 85.40 ሚ | 10,775.00% |
ነፃ የገንዘብ ፍሰት | 154.31 ሚ | 111.86% |
ስለ
Emergent BioSolutions Inc. is an American multinational specialty biopharmaceutical company headquartered in Gaithersburg, Maryland. It develops vaccines and antibody therapeutics for infectious diseases and opioid overdoses, and it provides medical devices for biodefense purposes.
Among the company's products are the controversial BioThrax, the only anthrax vaccine licensed by the U.S. Food and Drug Administration and Narcan for the emergency treatment of opioid overdose. The company also manufactures pharmaceuticals for infectious diseases like cholera and typhoid.
During the COVID-19 pandemic, Emergent BioSolutions also produced Johnson & Johnson/Janssen and Oxford–AstraZeneca vaccines at one of its plants; however, this was marked by contamination and other production issues, and millions of doses of vaccine had to be discarded. Wikipedia
ዋና ሥራ አስፈጻሚ
የተመሰረተው
5 ሴፕቴ 1998
ዋና መሥሪያ ቤት
ሠራተኞች
1,600